Pirfenidone inhibits inflammatory responses and ameliorates allograft injury in a rat lung transplant model

These results suggest that pirfenidone, with its anti-tissue necrosis factor α activity, reduced neutrophil recruitment and iron accumulation, hence limiting the acute lung allograft injury.